RecruitingNot ApplicableNCT06094205

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

Understanding and Restoring Speech Production Using an Intracortical Brain-computer Interface

Sponsor

Leigh R. Hochberg, MD, PhD.

Enrollment

2 participants

Start Date

Oct 16, 2023

Study Type

INTERVENTIONAL

Conditions

Anarthria Amyotrophic Lateral Sclerosis Spinal Cord Injuries Dysarthria locked-in Syndrome Muscular Dystrophies Brain Stem Infarctions tetraplegia

Summary

The goal of this study is to improve our understanding of speech production, and to translate this into medical devices called intracortical brain-computer interfaces (iBCIs) that will enable people who have lost the ability to speak fluently to communicate via a computer just by trying to speak.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called BrainGate Neural Interface System for people with amyotrophic lateral sclerosis, anarthria, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.